CONTRAST-INDUCED ACUTE KIDNEY INJURY. RISK FACTORS
DOI:
https://doi.org/10.54890/.v4i4.1274Abstract
Modern medicine makes extensive use of a variety of therapeutic and diagnostic procedures using contrast media. In this connection, there was a problem of development of X-ray contrast nephropathy. Several authors highlighted several risk factors, such as patient age, concomitant diabetes mellitus, anemia, kidney failure initial and others. But in spite of the large number of clinical studies, many questions of contrast-induced nephropathy to the present day are not quite clear, that it leads to the need for further research in this area.
Keywords:
contrast-induced nephropathy, contrast agents, CKD, diabetes mellitus.References
1. Миронова О.Ю. Индуцированная контрастными веществами нефропатия. Тер.архив 2013; том 85. №6: стр. 90-95.
2. Шульженко Л.В., Першуков И.В., Батыралиев Т.А. Контраст-индуцированная нефропатия. Фокус напрофилактику. Интервенц. Кард. 2010; 20: 47-59.
3. Ahuja TS, Niaz N, Agraharkar M. Contrast-inducednephrotoxicity in renal allograft recipients. Clin Nephrol. 2000 Jul;54(1):11-14.
4. Bachorzewska Gajewska, J.S. Malyszko et alUndiagnosed renal impairment in patients with and without diabeteswith normal serum creatinine undergoing percutaneous coronary intervention. Nephrology 2006; Vol.11, (6): P. 549-554.
5. Bagshaw S.M., Culleton B.F. Contrast-inducednephropathy: Epidemiology and prevention. Minerva Cardioangiol 2006; 54:109-129.
6. Barrett B.J., Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 1993; 188: 171-178.
7. Bartholomev B.A., Harjai K.J., Dukkipati S. et al. Impactof nephropathy after percutaneous coronary intervention and metod for risk stratification. Am. J. Cardiol. 2004; 93:1515-1519.
8. Berns A.S. Nephrotoxicity of contrast media. Kidney Int1989; 36:730-740.
9. Вrown J.R., Devries J.T., Piper W.D., et al. Serious renal dysfunction after percutaneous coronary intervention can be predicted. Am. Heart. J. 2008; 155: 260-266.
10. McCullough P.A., Bertrand M.E., Brinker J.A. et al. metaanalysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J. Am. Coll. Cardiol. 2006; 48:692-699
11. McCullough P.A., Wolyn R., Rocher L.L. et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am. J. Med. 1997; 103: 368-375.
12. Freeman R.V., O Donnell M., Share D., et al. Nephropathyrequiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am. J. Cardiol. 2002; 90 1068-1073.
13. Gruberg L., Mints J.S., Mehran R et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency. J. Am. Coll. Cardiol. 2000; 36: 1542-1548.
14. Haider M., Yessayan L., Venkat K.K., et.al. Incidence of contrast-induced nephropathy in kidney transplant recipients 2015 Mar;47(2):379-383.
15. Hall K.A., Wong R.W., Hunter G.C. et al. Contrast induced nephrotoxicity: The effects of vasodilator therapy. J. Surg Res., 1992; 53: 317-320.
16. Jin Wi, Young-Guk Ko, Dong-Ho Shin et al. Prediction of сontrast-induced nephropathy with persistent renal dysfunction and adverse long-term outcomes in patients with acute myocardial infarction using the Mehran risk score. Clin Cardiol. 2013; 36(1):46-53.
17. Jo S.H., Youn T.J., Koo B.K. et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: The RECOVER study: A randomized controlled trial. J. Am. Coll. Cardiol. 2006; 48: 924-930.
18. Dangas G., Iakovou I., Nikolsky E. et al. Сontrast-induced nephropathy after percutaneous coronary intervention is relation to chronic kidney disease and hemodynamic variables. Am. J. Cardiol. 2005; 95: 13-19.
19. Katholi R.E., Woods W.T. Jr., Taylor G.J. et al. Oxygen free radicals and contrast nephropathy. Am. J. Kidney. Dis. 1998; 32: 64-71.
20. Katzberg R.W., Lamba R. Contrast-induced nephropathy after intravenous administration: Fact or fiction? Radiol. Clin. North. Am. 2009; 47: 789-800.
21. Kurnik B.R., Allgren R.L., Genter F.C. et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am. J. Kidney Dis., 1998, 31: 674-680.
22. Levy E.M., Viscoli C.M., Horvitz R.I. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275: 1489-1494.
23. Lindsay J., Apple S., Pinnow E.E. et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late advers events in patients with normal baseline serum creatinine. Catheter. Cardiovasc. Interv. 2003; 59: 338-343.
24. Marenzi G., Lauri G., Assanelli E. et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J. Am. Coll. Cardiol. 2004; 44: 1780-1785.
25. Mehran R. ICON-A prospective, randomized, placebocontrolled trial of ioxaglate versus iodixanol in patients at increased risk for contrast nephropathy. Proceedings of Transcatheter Cardiovascular Therapeutics, 2006; 3:10.
26. Mehran R., Aymong E.D., Nikolsky E. et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J. Am. Coll.Cardiol. 2004; 44: 1393-1399.
27. Mehran R. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. Suppl. 2006. № 100: 11-15.
28. Messana J.M., Cieslinski D.A., Humes H.D. Comparison of toxicity of radiocontrast agents to renal tubule cells in vitro. Ren. Fail. 1990;12: 75-82.
29. Nikolsky E., Mehran R., Lasic Z. et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int., 2005; 67: 706-713.
30. Parfrey P.S., Griffiths S.M., Barret B.J. et al. Contrast material –induced renal failure in pations in with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. New Engl. J. Med. 1989; 320: 143-149.
31. Rich M.W., Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch. Intern. Med. 1990; 150: 1237-1242.
32. Rihal C.S.,Textor S.C.,Grill D.E. et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
33. Rudnick M.R., Goldfarb S., Wexler L. et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47: 254-261.
34. Stylianos A. Pyxaras, Gianfranco Sinagra, Fabio Mangiacapra, et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. Am. J. Cardiology 2013; 111(5): 684-68.
35. Thomsen H.S., Morcos S.K., Contrast media and the kidney: European society of urogenital reradiology (ESUR) guidelines. Br.J. Radiol. 2003; 76: 513–518.
36. Toprak O. Risk markers for contrast-indused nephropathy. Am.J. Med. Sci. 2007; 334:283-290.
Downloads
Published
How to Cite
Issue
Section
